Table 3.
Antimicrobial Susceptibility Profiles in Enterobacteriaceae (n=125)
| Ag+-R | Ag+-S | P | silS-P | silS-N | P | |
|---|---|---|---|---|---|---|
| n=9 (%) | n=116 (%) | n=24 (%) | n=101 (%) | |||
| Ceftriaxone | 9 (100) | 55 (47.4) | 0.003 | 18 (75) | 46 (45.5) | 0.012 |
| Ceftazidime | 9 (100) | 31 (26.7) | <0.001 | 14 (58.3) | 26 (25.7) | 0.003 |
| Cefepime | 9 (100) | 19 (16.4) | <0.001 | 9 (37.5) | 19 (18.8) | 0.059 |
| Aztreonam | 9 (100) | 34 (29.3) | <0.001 | 14 (58.3) | 29 (28.7) | 0.009 |
| Imipenem | 8 (88.9) | 9 (7.8) | <0.001 | 4 (16.7) | 13 (12.9) | 0.740 |
| Meropenem | 8 (88.9) | 8 (6.9) | <0.001 | 4 (16.7) | 12 (11.9) | 0.508 |
| Amikacin | 0 (0) | 5 (4.3) | 1.000 | 1 (4.2) | 4 (4) | 1.000 |
| Gentamicin | 9 (100) | 32 (27.6) | <0.001 | 12 (50) | 29 (28.7) | 0.055 |
| Levofloxacin | 7 (77.8) | 34 (29.3) | 0.006 | 8 (33.3) | 33 (32.7) | 1.000 |
| Ciprofloxacin | 8 (88.9) | 45 (38.8) | 0.004 | 12 (50) | 41 (40.6) | 0.492 |
| Trimethoprim/sulfamethoxazole | 9 (100) | 54 (46.6) | 0.003 | 15 (62.5) | 48 (47.5) | 0.256 |
Note: Significant differences are indicated in bold font.